# mifepristone Type: Product Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/mifepristone Canonical HTML page: https://getbiobrief.com/entity/mifepristone ## Timeline - **2026-03-19**: Media Backlash — Health experts and advocacy groups label the bill's scientific claims regarding water pollution as unverified. - **2026-03-18**: Bill Introduction — Rep. Mary Miller introduces the Clean Water For All Life Act in the House. - **2026-03-18**: Press Conference — Miller and Kristan Hawkins (Students for Life) present the bill as an environmental protection measure. - **2026-03-16**: Law Signed — Governor signs the law, enabling the Department of Corrections to begin distribution to providers. - **2026-03-14**: Legislation Passed — Washington legislature passes bill to clarify state distribution authority. - **2026-03-12**: Missouri Pause Request — DOJ files a request in federal court to pause the Missouri-led lawsuit citing an ongoing FDA review. - **2026-03-11**: Hawley Federal Bill — Senator Josh Hawley introduces a bill in the Senate to ban mifepristone nationwide. - **2026-01-15**: Louisiana Pause Request — DOJ asks Louisiana to pause its separate lawsuit; request is rejected by AG Liz Murrill. - **2025-10-01**: Missouri Lawsuit Filed — Missouri, Kansas, and Idaho file suit against the FDA to restrict mifepristone access. - **2024-06-13**: SCOTUS Ruling — Supreme Court preserves access to mifepristone on standing grounds, but litigation continues. - **2024-06**: SCOTUS Ruling — Supreme Court preserves access to mifepristone by ruling plaintiffs lacked standing in FDA challenge. - **2023-04-04**: Initial Stockpile Purchase — Governor Inslee orders 30,000 doses of mifepristone following a Texas court ruling. - **2022-06**: Dobbs Decision — SCOTUS overturns Roe v. Wade, triggering state-level bans and increasing demand for pills. - **2021-12**: Telehealth Shift — FDA permanently removes the requirement that mifepristone be dispensed in person. - **2016-03**: Label Update — FDA expands usage to 70 days gestation and reduces required office visits. ## Recent coverage (5 stories) ### Medication Abortion Dominates US Market Amid Escalating Regulatory Warfare 2026-03-24 07:47:20 · Sentiment: Neutral · Impact: 7/10 · Sources: 2 Medication abortion has surged to account for the majority of pregnancy terminations in the U.S., driven by telehealth expansion and mail-order access. This shift has catalyzed a sophisticated legal and legislative counter-offensive aimed at the FDA's regulatory authority and the distribution of pharmaceutical products. Full story: https://getbiobrief.com/story/medication-abortion-market-trends-2026 ### Georgia Murder Charge Over Abortion Pills Signals New Pharma Legal Risks 2026-03-20 21:58:51 · Sentiment: Strongly negative · Impact: 8/10 · Sources: 7 A Georgia woman has been charged with murder after allegedly using medication to induce an abortion, marking a significant escalation in the criminalization of self-managed reproductive care. This case highlights the growing legal and regulatory volatility surrounding the distribution and use of FDA-approved abortion pills in restrictive jurisdictions. Full story: https://getbiobrief.com/story/georgia-abortion-pill-murder-charge-analysis ### GOP Bill Targets Abortion Pill Access via Environmental Water Safety Regulations 2026-03-20 00:33:56 · Sentiment: Negative · Impact: 6/10 · Sources: 3 House Republicans have introduced the Clean Water For All Life Act, a bill that seeks to restrict abortion pill access by framing fetal remains as environmental pollutants. The legislation would mandate 'catch kits' for patients, ban telehealth prescriptions, and impose severe criminal penalties including five-year prison sentences. Full story: https://getbiobrief.com/story/gop-clean-water-act-abortion-pills ### Washington State Law Streamlines Abortion Pill Stockpile Distribution 2026-03-16 20:46:04 · Sentiment: Neutral · Impact: 6/10 · Sources: 2 Washington Governor has signed legislation authorizing the state to distribute its 30,000-dose stockpile of mifepristone to private and non-profit healthcare providers. The law resolves previous licensing hurdles that prevented the state's Department of Corrections from acting as a wholesale distributor for reproductive health medications. Full story: https://getbiobrief.com/story/washington-abortion-pill-stockpile-distribution-law ### DOJ Seeks Pause in Missouri Mifepristone Suit Amid FDA Review Strategy 2026-03-13 00:35:09 · Sentiment: Negative · Impact: 8/10 · Sources: 2 The Department of Justice has requested a federal court to pause a multi-state lawsuit against the FDA regarding the abortion pill mifepristone. The move suggests a strategic effort to allow the FDA to conduct its own internal review of the drug's safety and distribution protocols. Full story: https://getbiobrief.com/story/doj-missouri-mifepristone-lawsuit-pause --- This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.